NovaBay Pharmaceuticals, Inc. Debt/Assets

Debt/Assets of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Debt/Assets growth rates and interactive chart.


Highlights and Quick Summary

  • Debt/Assets for the quarter ending June 30, 2022 was 10.54% (a 9.45% increase compared to previous quarter)
  • Year-over-year quarterly Debt/Assets increased by 558.75%
  • Annual Debt/Assets for 2021 was 2.3% (a 121.15% increase from previous year)
  • Annual Debt/Assets for 2020 was 1.04% (a -97.12% decrease from previous year)
  • Annual Debt/Assets for 2019 was 36.06% (a Infinity% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Debt/Assets of NovaBay Pharmaceuticals, Inc.

Most recent Debt/Assetsof NBY including historical data for past 10 years.

Interactive Chart of Debt/Assets of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Debt/Assets for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 10.54% 9.63%
2021 2.3% 1.6% 2.23% 2.88% 2.3%
2020 3.3% 4.1% 10.88% 35.72% 1.04%
2019 36.06% 11.54% 38.79% 23.66% 36.06%
2018 0.0% 0.0% 0.0% 0.0% 0.0%
2017 0.0% 0.0% 0.0% 0.0% 0.0%
2016 0.0% 0.0% 7.48% 62.12% 0.0%
2015 32.6% 0.0% 0.0% 0.0% 32.6%
2014 0.0% 0.0% 0.0% 0.0% 0.0%
2013 0.0% 0.0% 0.0% 0.0% 0.0%
2012 0.0% 0.0% 0.0% 0.0% 0.0%
2011 0.0% 0.0% 0.0%

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology